Clinical trial
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
NCT03326037 is registered in ClinicalTrials.gov with AHMED ABDULQADER HAMMOUDA ABOU SHALL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
- Lead sponsor
- AHMED ABDULQADER HAMMOUDA ABOU SHALL
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- June 30, 2020
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.